1-3 of 3
Tina M. Albertson, MD PhD
Close
Sort by
Journal Articles

Transcend NHL 001: Immunotherapy with the CD19-Directed CAR T-Cell Product JCAR017 Results in High Complete Response Rates in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Jeremy S. Abramson, MD, Lia Palomba, MD, Leo I Gordon, MD, Matthew Lunning, DO, Jon Arnason, MD, Andres Forero-Torres, MD, Tina M. Albertson, MD PhD, Victoria Shaw Exton, Claire Sutherland, PhD, Benhuai Xie, PhD, Susan Snodgrass, MD, Tanya Siddiqi, MD
Journal: Blood
Blood (2016) 128 (22): 4192.
https://doi.org/10.1182/blood.V128.22.4192.4192
Published: 2016
Journal Articles

Interim Analysis of a Phase 1 Study of the Antibody-Drug Conjugate SGN-CD19A in Relapsed or Refractory B-Lineage Acute Leukemia and Highly Aggressive Lymphoma

Amir T Fathi, Robert Chen, MD, Tanya M. Trippett, Maureen M. O'Brien, MD, Daniel J DeAngelo, Bijal D. Shah, MD, Todd M. Cooper, DO, James M. Foran, MD, Gregory A. Hale, MD, Joseph Pressey, MD, Lewis B. Silverman, Raoul Tibes, MD, Stella Kim, MD, Tina M. Albertson, MD PhD, Larissa Sandalic, MS, Baiteng Zhao, PhD, Uma Borate, MD
Journal: Blood
Blood (2014) 124 (21): 963.
https://doi.org/10.1182/blood.V124.21.963.963
Published: 2014
Journal Articles

A First-In-Human Phase 1 Study Of The Antibody-Drug Conjugate SGN-CD19A In Relapsed Or Refractory B-Lineage Acute Leukemia and Highly Aggressive Lymphoma

Uma Borate, MD, Amir T. Fathi, MD, Bijal D. Shah, MD, Daniel J. DeAngelo, MD, Ph.D, Lewis B. Silverman, MD, Todd Michael Cooper, Tina M. Albertson, MD, PhD, Megan M. O'Meara, MD, Larissa Sandalic, MS, Faith Stevison, MS, Robert Chen, MD
Journal: Blood
Blood (2013) 122 (21): 1437.
https://doi.org/10.1182/blood.V122.21.1437.1437
Published: 2013